
Myeloid
The VariantPlex Myeloid panel is a targeted next-generation sequencing (NGS) product for acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and some lymphoid malignancy markers. Powered by Anchored Multiplex PCR (AMP™) chemistry, the panel enables deep strand-specific amplification of molecular barcoded DNA fragments for sequencing.
Thank You
- Key Features
- Specifications
- Gene Targets
- Additional Resources

Complex Variant Detection
Coverage combined with powerful bioinformatics enable variant detection in traditionally difficult regions like CEBPA & FLT3.

Low Input
AMP chemistry was purpose-built for wide sample compatibility, including low-input and degraded samples such as FFPE tissue.

Quantitative CNV Detection
Molecular barcoded fragments counting provides robust copy number analysis.

Simple, Lyophilized Workflow
Easy-to-handle lyophilized reagents and a simple workflow to minimize errors and reduce turn-around time.
Properties
Specifications
Gene Targets
75
Total Target Size
~125.4kb
Input DNA Required*
≤10ng
Coverage Uniformity >20% Mean
>99.8%
Hands-on Time
2.5 hours
Total Time
1 Day
Platform
Illumina®
Sample Types
Blood, Bone Marrow, PBL and FFPE
+Expected coverage uniformity at the recommended read depth. *Input recommendations for FFPE samples vary depending on PreSeq® RNA QC score; 50ng input recommended in absence of PreSeq screening

ABL1

ANKRD26

ASXL1

ATRX

BCOR

BCORL1

BRAF

BTK

CALR

CBL

CBLB

CBLC

CCND2

CDC25C

CDKN2A

CEBPA

CSF3R

CUX1

CXCR4

DCK

DDX41

DHX15

DNMT3A

ETNK1

ETV6

EZH2

FBXW7

FLT3

GATA1

GATA2

GNAS

HRAS

IDH1

IDH2

IKZF1

JAK2

JAK3

KDM6A

KIT

KMT2A

KRAS

LUC7L2

MAP2K1

MPL

MYC

MYD88

NF1

NOTCH1

NPM1

NRAS

PDGFRA

PHF6

PPM1D

PTEN

PTPN11

RAD21

RBBP6

RPS14

RUNX1

SETBP1

SF3B1

SH2B3

SLC29A1

SMC1A

SMC3

SRSF2

STAG2

STAT3

TET2

TP53

U2AF1

U2AF2

WT1

XPO1

ZRSR2
Product Information
Illumina®
- AB0108 - 8-reactions
- AB0109 - 16-reactions - Learn more
- Download Protocol
Archer® Analysis
Contact Us
